NVTA News and Press, Invitae Corporation

Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...

2024-02-14 05:07:40 ET Invitae ( OTC:NVTA ), backed by Softbank ( OTCPK:SFTBY ) and Cathie Wood's Ark Investment Management, filed for Chapter 11 bankruptcy protection , to address the genetic-testing company's ~$1.5B debt load.... Read the full article on Seeking Alp...

Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process PR Newswire – Company to Use its Cash on Hand to Operate its Business During the Proceedings and Continues to Serve Customers and Patients – SAN FRANCISCO , Feb. 13, 2024 /P...

2024-02-12 13:06:08 ET Summary PacBio has reported strong financial performance, with a 113% growth in Q4 revenue and a 56% growth for the year. The launch of the Revio and Onso products has contributed to PacBio's growth and expansion in the genomic research market. However, ...

2024-02-06 11:06:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Yesterday, shares of Invitae (NYSE: NVTA ) stock plummeted lower by over 75% after The Wall Street Journal reported that the genetic testing services company was preparing for...

2024-02-06 10:32:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Agrify (NASDAQ: AGFY ) stock is taking off on Tuesday as investors celebrate the company reaching a milestone at Lume Cannabis’ Michigan facility. According to a pr...

2024-02-06 10:18:08 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Invitae (NYSE: NVTA ) stock fell as much as 78% yesterday before it was ultimately halted because undisclosed news about the firm was pending. Many investors now expect that...

A look at the top 10 most actives in the United States Phunware Inc. (PHUN) rose 19.9% to $0.41 on volume of 260,182,609 shares Palantir Technologies Inc. Class A (PLTR) fell 1.8% to $16.72 on volume of 167,698,349 shares PROSHARES TRUST (SQQQ) rose 0.5% to $11.78 on volume of 155,646,888...

2024-02-05 11:24:32 ET More on Invitae Invitae's High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad Stocks To Watch: Energy Market Drama And Financial Earnings Headline Holiday Week Invitae Corporation 2023 Q3 - Results - Earnings Call Presentation ...

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics PR Newswire SAN FRANCISCO , Jan. 30, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partner...